STOCK TITAN

NeueHealth, Inc. - $NEUE STOCK NEWS

Welcome to our dedicated page for NeueHealth news (Ticker: $NEUE), a resource for investors and traders seeking the latest updates and insights on NeueHealth stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NeueHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NeueHealth's position in the market.

Rhea-AI Summary
NeueHealth, Inc. (NYSE: NEUE) will release its First Quarter 2024 financial results on May 8, 2024, followed by a conference call at 8:00 AM Eastern Time. Participants can join via telephone or webcast. Pre-registration is required for telephone participation. The earnings call will be accessible on NeueHealth's Investor Relations page.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.05%
Tags
conferences earnings
-
Rhea-AI Summary
NeueHealth, Inc. (NEUE) announced an incremental amendment to its credit facility with NEA, increasing the term loan commitment by $30 million. The proceeds will be used for general corporate purposes and to support the company's 2024 strategic priorities. NeueHealth will issue penny warrants to purchase up to 1,113,563 shares of common stock to lenders under the facility. The Audit Committee approved the omission to seek shareholder approval due to financial viability concerns. The NYSE has approved the company's reliance on an exception under its Listed Company Manual.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.57%
Tags
none
-
Rhea-AI Summary
NeueHealth, Inc. reported strong full-year 2023 results, with revenue reaching $1.2 billion and serving 461,000 consumers. The company expects Enterprise Adjusted EBITDA between $15 million and $25 million for 2024. Despite a net loss in 2023, NeueHealth is confident in its value-driven care model and aims for continued growth in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.13%
Tags
Rhea-AI Summary
NeueHealth, Inc. (NEUE) will report Fourth Quarter financial results on March 6, 2024, with a conference call at 8:00 AM Eastern Time. Participants can join via telephone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
NeueHealth, Inc.

NYSE:NEUE

NEUE Rankings

NEUE Stock Data

51.81M
8.05M
Hospital & Medical Service Plans
United States of America
DORAL